MAN-04008-001 Rev. 001 Page 27 of 27
BIBLIOGRAPHY
1. Solomon D., Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S,
Sherman
M,
Wilbur D, Wright T, Young N, for the Forum Group Members and the 2001 Bethesda
Workshop. The 2001 Bethesda System Terminology for Reporting Results of Cervical
Cancer. JAMA. 2002;287:2114-2119.
2. Jones HW. Impact of The Bethesda System, Cancer 77 pp. 1914-1918, 1995.
3. American Cancer Society. Cancer Facts and Figures, 1995.
4. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. ThinPrep Pap Test. Accuracy for glandular
disease. Acta Cytol 1999; 43: 81-5
5. Bai H, Sung CJ, Steinhoff MM: ThinPrep Pap Test promotes detection of glandular lesions
of the endocervix. Diagn Cytopathol 2000;23:19-22
6. Carpenter AB, Davey DD: ThinPrep Pap Test: Performance and biopsy follow-up un a university
hospital. Cancer Cytopathology 1999; 87: 105-12
7. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap test.
Diagn Cytopathol 2000; 23: 260-5
8. Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R. ThinPrep detection of cervical and
endometrial adenocarcinoma: A retrospective cohort study. Cancer Cytopathology 2002; 96: 338-43
9. Wang N, Emancipator SN, Rose P, Rodriguez M, Abdul-Karim FW. Histologic follow-up of atypical
endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear. Acta Cytol 2002;
46: 453-7
TECHNICAL SERVICE AND PRODUCT INFORMATION
For
technical service and assistance related to use of the ThinPrep 5000 processor, contact Hologic:
Telephone: 1-800-442-9892 Fax: 1-508-229-2795
For international or toll-free blocked calls, please contact 1-508-263-2900.
Email: info@hologic.com
Hologic, Inc.
250 Campus Drive
Marlborough, MA 01752
1‐800‐442‐9892
www.hologic.com
©2014 Hologic, Inc. All rights reserved.
AW-11239-001 Rev. 001
6-2014
To Previous Page
Loading...
